Johnny Mahlangu, Howard Levy, Marina V Kosinova, Heghine Khachatryan, Bartosz Korczowski, Levani Makhaldiani, Genadi Iosava, Martin Lee, Frank Del Greco. Res Pract Thromb Haemost 2021
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.
Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede. Blood 2021
Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede. Blood 2021
100
Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
R Titapiwatanakun, C Moir, R K Pruthi, P L Stavlo, K A Schmidt, V Rodriguez. Haemophilia 2009
R Titapiwatanakun, C Moir, R K Pruthi, P L Stavlo, K A Schmidt, V Rodriguez. Haemophilia 2009
100
Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
100
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
100
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
100
Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction model.
F Rode, K Almholt, M Petersen, M Kreilgaard, M Kjalke, D M Karpf, A V Groth, P B Johansen, L F Larsen, M Loftager,[...]. J Thromb Haemost 2018
F Rode, K Almholt, M Petersen, M Kreilgaard, M Kjalke, D M Karpf, A V Groth, P B Johansen, L F Larsen, M Loftager,[...]. J Thromb Haemost 2018
100
BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice.
Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M Holthaus,[...]. Blood 2020
Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M Holthaus,[...]. Blood 2020
100
Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.
Johannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, Flora Peyvandi, Jean-François Schved, Johan Szamosi, Bent Winding, Stefan Lethagen. BMJ Open 2019
Johannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, Flora Peyvandi, Jean-François Schved, Johan Szamosi, Bent Winding, Stefan Lethagen. BMJ Open 2019
100
Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration.
A Supersaxo, W R Hein, H Steffen. Pharm Res 1990
A Supersaxo, W R Hein, H Steffen. Pharm Res 1990
100
Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1).
Robert Klamroth, Clemens Feistritzer, Ute Friedrich, Steven R Lentz, Kirsten Reichwald, Marek Zak, Pratima Chowdary. J Thromb Haemost 2020
Robert Klamroth, Clemens Feistritzer, Ute Friedrich, Steven R Lentz, Kirsten Reichwald, Marek Zak, Pratima Chowdary. J Thromb Haemost 2020
100
FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis.
Marie Cadé, Javier Muñoz-Garcia, Antoine Babuty, Marc Fouassier, Marie-Francoise Heymann, Paul E Monahan, Dominique Heymann. Drug Discov Today 2022
Marie Cadé, Javier Muñoz-Garcia, Antoine Babuty, Marc Fouassier, Marie-Francoise Heymann, Paul E Monahan, Dominique Heymann. Drug Discov Today 2022
100
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
100
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
100
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities.
Beate Bittner, Wolfgang Richter, Johannes Schmidt. BioDrugs 2018
Beate Bittner, Wolfgang Richter, Johannes Schmidt. BioDrugs 2018
100
Emicizumab: Review of the literature and critical appraisal.
E Carlos Rodriguez-Merchan, Leonard A Valentino. Haemophilia 2019
E Carlos Rodriguez-Merchan, Leonard A Valentino. Haemophilia 2019
100
Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice.
Q Shi, E L Kuether, J A Schroeder, S A Fahs, R R Montgomery. Haemophilia 2012
Q Shi, E L Kuether, J A Schroeder, S A Fahs, R R Montgomery. Haemophilia 2012
100
Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissue.
A Fatouros, Y Lidén, B Sjöström. J Pharm Pharmacol 2000
A Fatouros, Y Lidén, B Sjöström. J Pharm Pharmacol 2000
100
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
Maria Elisa Mancuso, Johnny N Mahlangu, Steven W Pipe. Lancet 2021
Maria Elisa Mancuso, Johnny N Mahlangu, Steven W Pipe. Lancet 2021
100
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
100
Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.
James R Fuller, Kevin E Knockenhauer, Nina C Leksa, Robert T Peters, Joseph D Batchelor. Blood 2021
James R Fuller, Kevin E Knockenhauer, Nina C Leksa, Robert T Peters, Joseph D Batchelor. Blood 2021
100
A fixed 'single vial' dose of subcutaneous desmopressin (DDAVP) produces adequate biologic responses for persons with mild haemophilia A.
Joseph Noye, John A Rowell, Beryl Zeissink, Alex Connolly, Jane A Mason. Haemophilia 2021
Joseph Noye, John A Rowell, Beryl Zeissink, Alex Connolly, Jane A Mason. Haemophilia 2021
100
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries.
Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.